We are live on ! Find out more
EEG

E.E. Geduld Portfolio holdings

AUM $178M
1-Year Est. Return 29.34%
This Fund
S&P 500
This Quarter Est. Return
+7.42%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$207M
AUM Growth
+$43.3M
Cap. Flow
+$4.36M
Cap. Flow %
2.1%
Top 10 Hldgs %
41.81%
Holding
434
New
117
Increased
50
Reduced
37
Closed
98

Top Buys

Rank Stock Value
1
ARIA
Ariad Pharmaceuticals Inc
ARIA
+$4.51M
2
DDD icon
3D Systems Corp
DDD
+$1.4M
3
CIEN icon
Ciena
CIEN
+$953K
4
VNCE icon
Vince Holding Corp
VNCE
+$906K
5
LEN icon
Lennar Class A
LEN
+$886K

Top Sells

Rank Stock Value
1
PCYC
PHARMACYCLICS INC
PCYC
+$2.37M
2
BLOX
Infoblox Inc
BLOX
+$1.46M
3
GWRE icon
Guidewire Software
GWRE
+$942K
4
PBYI icon
Puma Biotechnology
PBYI
+$880K
5
QLIK
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
+$856K

Sector Composition

Rank Sector Weight
1 Miscellaneous 41.04%
2 Financials 25.83%
3 Healthcare 10.16%
4 Consumer Discretionary 6.24%
5 Technology 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SKF icon
176
ProShares UltraShort Financials
SKF
$10.5M
$174K 0.08%
+156
New +$192K
ELGX
177
DELISTED
Endologix Inc
ELGX
$174K 0.08%
1,000
– –
NSPH
178
DELISTED
NANOSPHERE INC. COM NEW
NSPH
$172K 0.08%
3,750
– –
HOV icon
179
CALL
Hovnanian Enterprises
HOV
$743M
$166K 0.08%
1,000
– –
DMK
180
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$160K 0.08%
+357
New +$156K
PRKR
181
DELISTED
Parkervision Inc
PRKR
$159K 0.08%
+3,500
New +$135K
PCYO icon
182
Pure Cycle
PCYO
$275M
$158K 0.08%
25,000
+15,000
+150% +$92.4K
OSUR icon
183
OraSure Technologies
OSUR
$254M
$157K 0.08%
+25,000
New +$157K
ECTE
184
DELISTED
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
$157K 0.08%
50,000
– –
CHTP
185
DELISTED
CHELSEA THERAPEUTICS INT'L LTD
CHTP
$155K 0.07%
35,000
-15,000
-30% -$50.7K
FORM icon
186
FormFactor
FORM
$8.61B
$150K 0.07%
+25,000
New +$143K
EBIX
187
PUT
DELISTED
Ebix Inc
EBIX
$147K 0.07%
+10,000
New +$128K
HDNG
188
DELISTED
Hardinge Inc
HDNG
$145K 0.07%
10,000
– –
FCSC
189
DELISTED
Fibrocell Science Inc.
FCSC
$142K 0.07%
+2,333
New +$136K
BAC.WS.B
190
DELISTED
Bank Of America Corporation Ws B
BAC.WS.B
$135K 0.07%
175,000
– –
FBIO icon
191
Fortress Biotech
FBIO
$93.4M
$132K 0.06%
3,333
+1,666
+100% +$64.3K
CNTY icon
192
Century Casinos
CNTY
$34.6M
$130K 0.06%
+25,000
New +$136K
CBK
193
DELISTED
Christopher & Banks Corporation
CBK
$128K 0.06%
+15,000
New +$101K
EMKR
194
DELISTED
Emcore Corp
EMKR
$128K 0.06%
+2,500
New +$126K
TACT icon
195
Transact Technologies
TACT
$52.4M
$125K 0.06%
+10,000
New +$130K
JMBA
196
DELISTED
Jamba, Inc.
JMBA
$124K 0.06%
+10,000
New +$116K
SWC
197
DELISTED
Stillwater Mining Co
SWC
$123K 0.06%
+10,000
New +$113K
XRX icon
198
CALL
Xerox
XRX
$390M
$122K 0.06%
3,795
– –
SRNE
199
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$122K 0.06%
+15,000
New +$132K
EWJ icon
200
iShares MSCI Japan ETF
EWJ
$22.7B
$121K 0.06%
+2,500
New +$119K
6 7
8
9 10

Similar funds

BC
Bocage Capital San Francisco, California $185M AUM 61.49% 1-Year Est. Return
PFM
PacWest Financial Management Phoenix, Arizona $169M AUM 8.84% 1-Year Est. Return
SRP
Saddle Road Partners Omaha, Nebraska $197M AUM 13.19% 1-Year Est. Return
CF
CenterStar Fund Chicago, Illinois $159M AUM 13.43% 1-Year Est. Return
SA
Steadfast Advisors New York $204M AUM 28.42% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
SIG
Stanford Investment Group Mountain View, California $205M AUM 7.44% 1-Year Est. Return
VWM
Vector Wealth Management Minneapolis, Minnesota $142M AUM 10.42% 1-Year Est. Return

E.E. Geduld's Q4 2013 Portfolio in Review

As of Q4 2013, E.E. Geduld held 434 positions worth $207M, up 26% from $164M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

E.E. Geduld's Q4 2013 filing shows 117 new, 50 increased, 37 reduced and 98 closed positions. Its largest new stake was Ariad Pharmaceuticals Inc: 835,100 shares worth $5.7M. The largest sale was PHARMACYCLICS INC, an estimated $2.37M.

By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, up from 34% a quarter earlier, followed by Financials and Healthcare.

  • E.E. Geduld's largest Q4 2013 buy was Ariad Pharmaceuticals Inc: 835,100 shares worth $5.7M.
  • E.E. Geduld added most to Hess in Q4 2013, an estimated $812K increase.
  • E.E. Geduld's biggest Q4 2013 reduction was PHARMACYCLICS INC, cutting an estimated $2.37M.
  • E.E. Geduld fully exited Infoblox Inc in Q4 2013, selling an estimated $1.46M.
  • E.E. Geduld's ten largest holdings make up 42% of its $207M portfolio in Q4 2013.
  • E.E. Geduld opened 117 new positions and closed 98 in Q4 2013.
  • E.E. Geduld's portfolio value rose 26% quarter-over-quarter to $207M.

Based on E.E. Geduld's 13F filing for Q4 2013, filed 23 Jan 2014.